Pulse Biosciences Inc.
(PLSE)
undefined
undefined%
At close: undefined
17.65
0.17%
After-hours Dec 13, 2024, 04:00 PM EST
Company Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company.
It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.
The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015.
Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
Pulse Biosciences Inc.
| Country | United States |
| IPO Date | May 18, 2016 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 56 |
| CEO | Burke T. Barrett |
Contact Details
Address: 3957 Point Eden Way Hayward, California United States | |
| Website | https://www.pulsebiosciences.com |
Stock Details
| Ticker Symbol | PLSE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001625101 |
| CUSIP Number | 74587B101 |
| ISIN Number | US74587B1017 |
| Employer ID | 46-5696597 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Burke T. Barrett | President, Chief Executive Officer & Director |
| Darrin R. Uecker | Chief Technology Officer & Director |
| David Danitz | Senior Vice President of Engineering |
| Dr. Richard Nuccitelli Ph.D. | Chief Science Officer |
| Edison Manuel | Vice President of Operations |
| Kenneth B. Stratton Esq., J.D. | General Counsel & Corporate Secretary |
| Kevin P. Danahy | Chief Commercial Officer |
| Mitchell E. Levinson | Chief Strategy Officer |
| Patty Perla | Vice President of Human Resources |
| Robert W. Duggan | Executive Co-Chairman |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 06, 2024 | 8-K | Current Report |
| Nov 26, 2024 | 8-K | Current Report |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 30, 2024 | 10-Q | Quarterly Report |
| Oct 30, 2024 | 8-K | Current Report |
| Sep 30, 2024 | 4 | Filing |
| Aug 19, 2024 | 10-Q | Quarterly Report |
| Aug 15, 2024 | NT 10-Q | Filing |
| Aug 13, 2024 | 4 | Filing |
| Aug 13, 2024 | 3 | Filing |